Article

An algorithm for drug discovery based on deep learning with an example of developing a drug for the treatment of lung cancer

2023-05-07

Abstract excerpt

We have designed an algorithm implemented in a software platform for the development of new anti-tumor drugs in the form of small molecules. Several molecules were generated for the treatment of patients with lung cancer as an example. At the initial stage, we identified the targets for the therapy. Firstly, we evaluated the expression profile of the genes most associated with poor clinical outcome in patients wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 94ab8062-840e-5494-805d-5872917e216d
DOI: 10.1101/2023.05.07.538843

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An algorithm for drug discovery based on deep learning with an example of developing a drug for the treatment of lung cancerDOI 10.1101/2023.05.07.538843Read

Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning TechniquesSemantic proximity Read

Creating a Novel Deep Learning Pipeline to Generate and Screen Molecules for Hormone-Positive Breast Cancer TreatmentSemantic proximity Read

Predictive Modeling of Clinical Trial Outcomes for Novel Drugs using Digital Twin Patient Cohorts and GenerativeAISemantic proximity Read

PanGu Drug Model: Learn a Molecule Like a HumanSemantic proximity Read

De novo drug design based on patient gene expression profiles via deep learningSemantic proximity Read

Discovering the mechanism of action of drugs with a sparse explainable network.Semantic proximity Read

Increasing prediction accuracy of pathogenic staging by sample augmentation with a GAN.Semantic proximity Read

Machine learning based personalized drug response prediction for lung cancer patients.Semantic proximity Read

Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.Semantic proximity Read

Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity Read

Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment SelectionSemantic proximity Read

AnimalGAN: A Generative Adversarial Network Model Alternative to Animal Studies for Clinical Pathology AssessmentSemantic proximity Read